Penn State University
University Park, Pennsylvania, 16802, United States
NCT Number: NCT01173042
This pilot study will investigate the effects of acute peanut consumption on markers of inflammation, triglycerides and glucose. The hypothesis is that a high glucose/SFA meal will increase postprandial production of the inflammatory marker, C-reactive protein (CRP), and that the addition of peanuts to the control meal will reduce the production of CRP, as well as triglycerides and glucose.
Looking for future studies?
Notify Me30 year–50 year
Male
Interventional
Phase 1
University Park, Pennsylvania, 16802, United States
Previous research has demonstrated that a single meal high in saturated fatty acids (SFA) and glucose can induce increases in IL-6, TNF-α and CRP in abdominally obese and diabetic subjects. As over two-thirds of the U.S. population is overweight or obese, it is important to identify foods that can attenuate postprandial increases in lipids, glucose and inflammation in this population. Therefore, the purpose of the pilot study is to determine whether a high SFA / high glucose control meal will induce an acute inflammatory response in overweight individuals, and whether the addition of peanuts to this meal will ameliorate this response. To ensure that these effects are due to peanuts, and not to the increase in total fat, we will compare this response to another test meal that includes an oil blend with a similar fatty acid composition to peanuts.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Shake containing 3.0oz of peanuts (including skin) + control (heavy whipping cream, glucose and chocolate syrup)
An oral liquid glucose (75g) and fat (high saturated fat from 60g heavy whipping cream) load. Chocolate syrup is added for flavor.
Shake containing an oil blend (sunflower, sesame, olive and palm oils) + control (heavy whipping cream, glucose and chocolate syrup). The amount of oil added to the control will provide an equivalent amount of fat to that provided in 3 oz (85g) of peanuts
Time frame: 0min
Time frame: 60 min
Time frame: 120 min
Time frame: 240 min
Time frame: 0 min
Time frame: 0 min
Time frame: 0 min
Time frame: 60 min
Time frame: 120 min
Time frame: 240 min
Time frame: 60 min
Time frame: 120 min
Time frame: 240 min
Time frame: 60 min
Time frame: 120 min
Time frame: 240 min
Penn State University
Other
Pilot Study of the Effect of Peanut Consumption on Postprandial Inflammatory Status, Glucose and Triglycerides
Acronym: PKEPEANUT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03059472
Behavior, Body Weight
Clyde, New York, United States
View Trial DetailsNCT02499731
Behavior, Body Weight
Broadus, Montana, United States
View Trial DetailsNCT02019264
Body Weight, Cardiovascular Disease
Alexander City, Alabama, United States
View Trial DetailsNCT00498459
Behavior, Body Weight
Strasbourg, France
View Trial Details